Health and Healthcare

AstraZeneca : AZN

All AstraZeneca Articles

221 Articles

Douglas A. McIntyre | Jan 6, 2012 at 6:39 AM EST

Short Sellers Help Push Dendreon Higher

Dendreon (NASDAQ: DNDN) soared almost 40% in value, or $3.02 a share, in active trading on Thursday after announcing that…

Jon C. Ogg | Jan 5, 2012 at 8:21 AM EST

Top Analyst Upgrades & Downgrades (AZN, BLK, BRCM, CEG, ED, EBAY, ERIC, EXC, GOOG, NFLX, NOK, PSUN, SOL, SAP, SNY, TRN, UPS, VVUS, VMW)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms…

Paul Ausick | Dec 20, 2011 at 12:10 PM EST

AstraZeneca Drug Fails Trial, Really Hurts Partner (AZN, TRGT)

Pharmaceutical company AstraZeneca plc (NYSE: AZN) is looking for another big winner to replace its Nexium heartburn drug and its…

Douglas A. McIntyre | Dec 8, 2011 at 6:24 AM EST

A Slew of Layoffs

Layoffs were part of the business news yesterday. Enough people lost jobs in a series of three “downsizings” to reminds…

Paul Ausick | Nov 21, 2011 at 1:47 PM EST

Probing for Value in Big Pharmaceutical Stocks (JNJ, PFE, AZN, BMY, MRK)

It now costs about $1 billion to get a new drug to market, or, if a company is unlucky, $1…

Paul Ausick | Nov 8, 2011 at 4:07 PM EST

24/7 Wall St. Closing Bell (AIXG, AZN, HON, HUM, PAA, ALU, FTEK, IRDM, XIDE, WMS, JRCC, PKT, RJET, OPXA, DYN, TRGT, MSSR, SZYM)

Equities started the day with a solid move up, but lost momentum after about half an hour. The downward move…

Jon C. Ogg | Nov 8, 2011 at 8:10 AM EST

Top Analyst Upgrades & Downgrades (AIXG, ALU, AZN, CXW, EMR, GSK, HON, HUM, KEX, MCHP, OVTI, PAA, RAX, STJ, TEVA, TRMB, VRTX, WFM)

These are some of Tuesday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls. Aixtron SE (NASDAQ:…

Jon C. Ogg | Oct 12, 2011 at 2:10 PM EDT

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent…

Douglas A. McIntyre | Aug 4, 2011 at 9:26 AM EDT

Lipitor OTC: What Next? (PFE, MRK, AZN, SNY, BMY, LLY, JNJ, AMGN)

Once patent protection expires on a prescription drug, the drug’s maker can take a serious beating in revenue and profitability.…

Jon C. Ogg | Jul 22, 2011 at 8:16 AM EDT

Top Analyst Upgrades & Downgrades (AMD, AXP, AZN, CCI, DF, HBAN, ERIC, MHS, NFLX, SNDK, SZYM, TLAB, UNH)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday…

Jon C. Ogg | Jun 9, 2011 at 3:39 PM EDT

Screening the Highest Dividends in Defensive Stocks (MO, RAI, LO, KMB, LLY, HNZ, CAG, TAP, DPS, AWK)

We may have just witnessed an oversold bounce in the stock market, or we may be in for more days…

Jon C. Ogg | Apr 18, 2011 at 11:01 AM EDT

Dividend Watch: Lilly Highlights Drug Sector Dividends Ahead of Earnings Season (LLY, PFE, MRK, AZN, GSK)

The drug sector has become rather boring and investors already know all about the ongoing patent expiration threats that loom…

Jon C. Ogg | Apr 14, 2011 at 11:38 AM EDT

Dividend Watch: Big Dividends in ADRs (AZN, GSK, NOK, TMX)

American Depository Receipts, or ADRs, are generally called American Depository Shares, or ADSs, now. We found after some routine screens…

Jon C. Ogg | Mar 2, 2011 at 8:17 AM EST

Top Analyst Upgrades & Downgrades (AZN, CNP, CEDC, FDO, GOOG, MAR, MGM, OPTR, CRM, SONS, UFPI, WFMI, XLNX, YHOO)

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning.…

Jon C. Ogg | Feb 4, 2011 at 12:17 PM EST

2011 Stock Buybacks on Fire, Over $34 Billion (PFE, UNP, GME, ERTS, GD, TUP, MHS, VZ, UNM, MO, AZN, SYMC, YUM, DGX, COH, TIF, INTC)

The method of using capital from the corporate treasury to return capital to shareholders via share repurchase programs has long…

1 … 11 12 13 14 15

AstraZeneca : AZN

All AstraZeneca Articles

Short Sellers Help Push Dendreon Higher

Top Analyst Upgrades & Downgrades (AZN, BLK, BRCM, CEG, ED, EBAY, ERIC, EXC, GOOG, NFLX, NOK, PSUN, SOL, SAP, SNY, TRN, UPS, VVUS, VMW)

AstraZeneca Drug Fails Trial, Really Hurts Partner (AZN, TRGT)

A Slew of Layoffs

Probing for Value in Big Pharmaceutical Stocks (JNJ, PFE, AZN, BMY, MRK)

24/7 Wall St. Closing Bell (AIXG, AZN, HON, HUM, PAA, ALU, FTEK, IRDM, XIDE, WMS, JRCC, PKT, RJET, OPXA, DYN, TRGT, MSSR, SZYM)

Top Analyst Upgrades & Downgrades (AIXG, ALU, AZN, CXW, EMR, GSK, HON, HUM, KEX, MCHP, OVTI, PAA, RAX, STJ, TEVA, TRMB, VRTX, WFM)

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Lipitor OTC: What Next? (PFE, MRK, AZN, SNY, BMY, LLY, JNJ, AMGN)

Top Analyst Upgrades & Downgrades (AMD, AXP, AZN, CCI, DF, HBAN, ERIC, MHS, NFLX, SNDK, SZYM, TLAB, UNH)

Screening the Highest Dividends in Defensive Stocks (MO, RAI, LO, KMB, LLY, HNZ, CAG, TAP, DPS, AWK)

Dividend Watch: Lilly Highlights Drug Sector Dividends Ahead of Earnings Season (LLY, PFE, MRK, AZN, GSK)

Dividend Watch: Big Dividends in ADRs (AZN, GSK, NOK, TMX)

Top Analyst Upgrades & Downgrades (AZN, CNP, CEDC, FDO, GOOG, MAR, MGM, OPTR, CRM, SONS, UFPI, WFMI, XLNX, YHOO)

2011 Stock Buybacks on Fire, Over $34 Billion (PFE, UNP, GME, ERTS, GD, TUP, MHS, VZ, UNM, MO, AZN, SYMC, YUM, DGX, COH, TIF, INTC)

History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now

Lucid Stock Is Deeply Oversold and We See 45% Gains Ahead

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

The West's Home Prices Just Fell 1.4% While the Rest of America Climbed. Here's Why.

History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now

Lucid Stock Is Deeply Oversold and We See 45% Gains Ahead

AstraZeneca : AZN

All AstraZeneca Articles

Short Sellers Help Push Dendreon Higher

Top Analyst Upgrades & Downgrades (AZN, BLK, BRCM, CEG, ED, EBAY, ERIC, EXC, GOOG, NFLX, NOK, PSUN, SOL, SAP, SNY, TRN, UPS, VVUS, VMW)

AstraZeneca Drug Fails Trial, Really Hurts Partner (AZN, TRGT)

A Slew of Layoffs

Probing for Value in Big Pharmaceutical Stocks (JNJ, PFE, AZN, BMY, MRK)

24/7 Wall St. Closing Bell (AIXG, AZN, HON, HUM, PAA, ALU, FTEK, IRDM, XIDE, WMS, JRCC, PKT, RJET, OPXA, DYN, TRGT, MSSR, SZYM)

Top Analyst Upgrades & Downgrades (AIXG, ALU, AZN, CXW, EMR, GSK, HON, HUM, KEX, MCHP, OVTI, PAA, RAX, STJ, TEVA, TRMB, VRTX, WFM)

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Lipitor OTC: What Next? (PFE, MRK, AZN, SNY, BMY, LLY, JNJ, AMGN)

Top Analyst Upgrades & Downgrades (AMD, AXP, AZN, CCI, DF, HBAN, ERIC, MHS, NFLX, SNDK, SZYM, TLAB, UNH)

Screening the Highest Dividends in Defensive Stocks (MO, RAI, LO, KMB, LLY, HNZ, CAG, TAP, DPS, AWK)

Dividend Watch: Lilly Highlights Drug Sector Dividends Ahead of Earnings Season (LLY, PFE, MRK, AZN, GSK)

Dividend Watch: Big Dividends in ADRs (AZN, GSK, NOK, TMX)

Top Analyst Upgrades & Downgrades (AZN, CNP, CEDC, FDO, GOOG, MAR, MGM, OPTR, CRM, SONS, UFPI, WFMI, XLNX, YHOO)

2011 Stock Buybacks on Fire, Over $34 Billion (PFE, UNP, GME, ERTS, GD, TUP, MHS, VZ, UNM, MO, AZN, SYMC, YUM, DGX, COH, TIF, INTC)

History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now

Lucid Stock Is Deeply Oversold and We See 45% Gains Ahead

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

Featured Reads

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

The West's Home Prices Just Fell 1.4% While the Rest of America Climbed. Here's Why.